EP Patent

EP1408967B1 — ARZNEIMITTELKOMPOSITIONEN AUF DER BASIS VON Tiotropium, Ciclesonide UND einem BETAMIMETIKum ZUR BEHANDLUNG VON ENTZÜNDLICHEN UND/ODER OBSTRUKTIVEN ATEMWEGSERKRANKUNGEN

Assigned to Boehringer Ingelheim Pharma GmbH and Co KG · Expires 2009-10-28 · 17y expired

What this patent protects

Patent listed against null.

Drugs covered by this patent

Patent Metadata

Patent number: EP1408967B1
Jurisdiction: EP
Classification: —
Expires: 2009-10-28
Drug substance claim: No
Drug product claim: No
Assignee: Boehringer Ingelheim Pharma GmbH and Co KG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.